Metraipolis › archive › dc_dadad3f54aa2

Stroke minimization through additive anti-atherosclerotic agents in routine treatment (SMAART) II: Rationale for a multi-country polypill phase 3 trial in… — Europe PMC PMID:41727852

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41727852
DOI
10.1016/j.neuros.2026.100020
License (as archived)
solo-consultazione
Archived
2026-11-06T14:39:09.918Z
SHA-256 of the archived text
3061e84df4179a4ec68d6f80dee6eed6c414f1fd6137b0d74b218bace4ce5cc9
Stable URL of this page
https://metraipolis.com/documento/dc_dadad3f54aa2

How to cite

Stroke minimization through additive anti-atherosclerotic agents in routine treatment (SMAART) II: Rationale for a multi-country polypill phase 3 trial in… — Europe PMC PMID:41727852 — Europe PMC (en), https://europepmc.org/article/MED/41727852 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_dadad3f54aa2 (Metraipolis archive dc_dadad3f54aa2, sha256 3061e84df4179a4ec68d6f80dee6eed6c414f1fd6137b0d74b218bace4ce5cc9)
BibTeX
@misc{dcdadad3f54aa2,
  title = {Stroke minimization through additive anti-atherosclerotic agents in routine treatment (SMAART) II: Rationale for a multi-country polypill phase 3 trial in… — Europe PMC PMID:41727852},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41727852},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_dadad3f54aa2; sha256 3061e84df4179a4ec68d6f80dee6eed6c414f1fd6137b0d74b218bace4ce5cc9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41727852. Agents can read the archived copy with the MCP tool read_document.